AC IMMUNE WKN: A2AR5F ISIN: CH0329023102 Kürzel: ACIU Forum: Aktien Thema: Hauptdiskussion

Habe nun aufgestockt

Bald steig ich ein. Guter kurs zur zeit.

Kein Stress

abgeht, trotz guter Grundlagen und neuen Forschungsergebnisse in Phase 2

Kann im Moment nicht ganz nachvollziehen was da abgegt

Shares of Swiss biotech co AC Immune SA rise 12% to $6.80 premarket ** Co says its Alzheimer's vaccine candidate, ACI-35.030, showed immune response in an early-to-mid stage trial ** Says vaccine produces strong antibodies that target the tau protein (pTau) that forms twisted fibres and tangles inside the brain ** Co says new trial result support ACI-35.030's advancement into late-stage development ** ACI-35.030 is being developed in collaboration with Johnson & Johnson's unit, Janssen Pharmaceuticals Inc ** Up to Thursday's close, ACIU had risen 17% YTD (Reporting by Dania Nadeem in Bengaluru) ((Dania.Nadeem@thomsonreuters.com;))

Die war kurz bei 6.50

Ein put wäre doch gut gewesen

Die Aktie ist minimal volatil, nix für schwache Gemüter 😂

Hab nochmals aufgestockt

Unglaublich, um ca 15:20h waren wir bei plus 11 prozent! Nun bei minus 4 🤮🤮🤮

Alter-2

Die Amis haben schön in die Suppe gespuckt

Heute noch 7€ 🔥🚀

AC Immune SA reported a quarterly adjusted loss of 22 rappen​​ per share for the quarter ended in September. The mean expectation of three analysts for the quarter was for a loss of 27 rappen per share. * Reported revenue was zero​; analysts expected CHF1.75 million. * AC Immune SA's reported EPS for the quarter was a loss of 22 rappen​. * The mean earnings estimate of analysts was unchanged in the last three months.​ * In the last 30 days there have been no earnings estimate revisions by analysts covering the company. * AC Immune SA shares had fallen by 8.9% this quarter and gained 18.2% so far this year. * The company reported a quarterly loss of CHF15.92 million. * Wall Street's median 12-month price target for AC Immune SA is $16.00 * The current average analyst rating on the shares is "strong buy" and the breakdown of recommendations is 3 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." This summary was machine generated November 11 at 02:30 p.m.

Morgen